Related by context. Frequent words. (Click for all words.) 62 CUDC 61 AEZS 61 NKTR 60 CRx 60 AP# [003] 60 Alpharadin 60 HGS ETR1 60 T DM1 59 IMGN# 59 gemcitabine 59 metastatic renal cell carcinoma 58 dasatinib 58 blinatumomab 58 INGN 58 ERBITUX 58 Taxotere R 58 Debio 57 HRPC 57 HspE7 57 Phase Ib 57 RDEA# 57 advanced NSCLC 57 antisense drug 57 4SC 57 sunitinib 57 Perifosine 56 Torisel 56 MGCD# [001] 56 resistant ovarian cancer 56 sorafenib 56 tesetaxel 56 Phase 2a trial 56 dose escalation study 56 Vectibix 56 docetaxel 56 CERE 56 hormone refractory prostate cancer 56 Marqibo 56 carfilzomib 56 ISIS # 55 CYT# 55 taxane 55 NSCLC 55 CTCE 55 vandetanib 55 FTY# 55 RG# [001] 55 evaluable patients 55 panitumumab 55 picoplatin 55 PF # [001] 55 Azixa 55 Phase 1b 55 monotherapy 55 mCRC 55 unresectable 55 ipilimumab 55 pemetrexed 55 perifosine 55 Cotara 55 metastatic melanoma 54 Phase 2b clinical 54 ZYBRESTAT 54 metastatic colorectal cancer 54 bortezomib 54 INCB# [002] 54 mg BID 54 Xcytrin 54 evaluable 54 Phase 2a clinical 54 interferon beta 1a 54 Phase IIa clinical 54 mitoxantrone 54 cutaneous T cell 54 adjuvant therapy 54 daclizumab 54 phase IIb 54 topotecan 54 Zerenex 54 satraplatin 54 Rexin G 54 TREANDA 54 pralatrexate 54 raltegravir 53 dose escalation 53 FOLOTYN 53 Phase IIa trial 53 VIDAZA 53 ARRY 53 Phase 2b study 53 fluorouracil 53 dose limiting toxicities 53 FOLFOX 53 TNFerade 53 carboplatin 53 humanized monoclonal antibody 53 DAVANAT R 53 PEG INTRON 53 dose escalation trial 53 XYOTAX 53 cetuximab